Literature DB >> 10086649

A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia.

P G Quinn1, M M Jamal, J D Carey, S Arora, T Harris, D E Johnston, A Sonnenberg.   

Abstract

OBJECTIVE: Infection with the hepatitis C virus (HCV) becomes chronic in 85% of the infected individuals. We studied risk factors that may predict clearance of HCV.
METHODS: A case-control study compared the association between risk factors and viral clearance. Viral clearance was defined as presence of a positive HCV antibody test plus negative HCV test by polymerase chain reaction (PCR). Forty-four cases and 214 controls with persistent viremia were identified in a database of patients evaluated at the Gastroenterology Clinic of the University of New Mexico.
RESULTS: Of all 258 HCV-antibody-positive patients, 17% had a negative test by PCR. The multivariate logistic regression revealed that a history of parenteral exposure and a long time interval since the most recent exposure were both associated with an increased likelihood of persistent viremia, whereas subjects who had been monogamous for longer time periods were more likely to have cleared HCV from their serum. A low serum level of ferritin also conferred protection against persistent viremia. Case and control subjects did not differ with respect to their demographic characteristics, occurrence of comorbid disease, previous medical history, occurrence of sexually transmitted diseases, blood group, and risky health or sexual practices.
CONCLUSIONS: These data suggest that route of exposure and time when exposure occurred are important in the development of persistent HCV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086649     DOI: 10.1111/j.1572-0241.1999.00934.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users.

Authors:  Basmattee Boodram; Ronald C Hershow; Scott J Cotler; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

Review 2.  Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-02-06

3.  Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.

Authors:  S Keating; S Coughlan; J Connell; B Sweeney; E Keenan
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

4.  Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Authors:  Fernando H Wolff; Sandra C Fuchs; Nêmora N T Barcellos; Paulo Ricardo de Alencastro; Maria Letícia R Ikeda; Ajácio B M Brandão; Maicon Falavigna; Flávio D Fuchs
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

5.  Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.

Authors:  Alice K Asher; Glenn-Milo Santos; Jennifer Evans; Emily K Dokubo; Tzong-Hae Lee; Jeffrey N Martin; Steven G Deeks; Leslie H Tobler; Michael Busch; Peter W Hunt; Kimberly Page
Journal:  AIDS       Date:  2013-11-13       Impact factor: 4.177

6.  The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.

Authors:  Karen H Seal; Alex Monto; Lorna Dove; Hui Shen; Eric Vittinghoff; Daniel Tracy; Erica Miller; Eva Lau; Teresa L Wright
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.